Flavonoids & Critically ill Patients: From Experimental Study to Clinical Practice

Prof. Wojciech Dabrowski, Medical University of Lublin, Poland, will be joining the 17th World Congress on Polyphenols Applications 2024 this September in Milan.

He will present his latest studies on Flavonoids & Critically ill Patients: From Experimental Study to Clinical Practice.

Presentation Highlights

• Highlight Xanthohumol as a flavonoid with potential therapeutic benefits, with an emphasis on its promise as an adjunctive therapy to enhance the efficacy of existing treatments for septic shock and pulmonary fibrosis.
• Present the rationale for using Xanthohumol in critically ill septic shock patients based on experimental studies.
• Summarize biochemical findings showing reduced pro-inflammatory cytokines and oxidative stress markers.
• Discuss clinical study results indicating improved outcomes for septic shock patients with Xanthohumol as adjunctive therapy.
• Present data on enhanced lung function and quality of life in pulmonary fibrosis patients, including those with post-COVID complications.
• Outline the necessary steps to translate experimental and preliminary clinical findings into routine clinical practice.
• Emphasize the need for personalized treatment approaches to optimize outcomes.
• Discuss future research opportunities, including novel delivery methods and targeted therapies.
• Highlight the potential for precision medicine approaches in Xanthohumol-based treatments for septic shock and pulmonary fibrosis.

Polyphenols Applications 2024 Congress
September 19-20, 2024 - Milan
Press Releases | Newsletter Archives
LinkedIn | Facebook